Aktienbewertung
Konkurrenz
| Ticker | Preis | Prognose 1J | Prognose 2J | Börsenwert | Div Yld | Wachstumsrate |
|---|---|---|---|---|---|---|
|
NYSE:LLY
Eli Lilly and
|
770.00 | -48,73% | -27,69% | 693.312,15 | 0,68% | 2,63% |
|
NYSE:JNJ
Johnson & Johnson
|
154.64 | 0% | 0% | 372.168,87 | 3,21% | 2,71% |
|
NYSE:MRK
Merck
|
131.19 | -10,02% | 3,18% | 332.278,86 | 2,35% | -19,03% |
|
NYSE:ABBV
AbbVie
|
166.42 | -23,06% | -12,89% | 293.875,72 | 3,73% | 7,03% |
|
LSE:AZN
AstraZeneca PLC
|
121.10 | 18,89% | 41,61% | 187.733,46 | 2,01% | 15,98% |
|
NYSE:ABT
Abbott Laboratories
|
104.09 | 2,43% | 15,17% | 181.078,48 | 2,11% | 9,04% |
|
NasdaqGS:AMGN
Amgen
|
312.47 | -12,26% | -3,47% | 167.619,75 | 2,88% | 5,31% |
|
LSE:GSK
GSK
|
17.75 | 7,44% | 23,26% | 72.385,16 | 3,27% | 0,79% |
|
NYSE:BMY
Bristol-Myers Squibb
|
44.03 | 61,74% | 72,08% | 89.253,22 | 5,45% | 13,54% |
|
NasdaqGS:GILD
Gilead Sciences Inc
|
67.72 | 20,9% | 30,15% | 84.363,86 | 4,55% | 0,15% |
|
XTRA:MRK
Merck KGaA
|
167.20 | 2,96% | 17,7% | 72.694,86 | 1,32% | 10,73% |
|
NYSE:MMM
3M
|
105.26 | 58,01% | 72,94% | 58.246,81 | 5,74% | -2,45% |
|
SWX:ALC
Alcon
|
80.08 | 9,95% | 25,4% | 39.591,55 | 0,3% | 8,65% |
|
SWX:LONN
Lonza Group
|
529.20 | -28,51% | -13,47% | 38.164,1 | 0,76% | 0,68% |
|
ENXTAM:DSFIR
DSM-Firmenich
|
107.45 | -59,05% | -43,62% | 28.504,75 | 2,33% | 0% |
|
XTRA:BAYN
Bayer
|
28.58 | 67,53% | 83,89% | 28.077,68 | 0,38% | 1,47% |
|
ENXTAM:PHIA
Koninklijke Philips N.V.
|
25.87 | 27,11% | 52,69% | 24.245,45 | 0% | -5,4% |
|
CPSE:GMAB
Genmab A/S
|
2041.00 | 64,8% | 124,4% | 131.830,48 | 0% | 22,71% |
|
XTRA:FRE
Fresenius SE & Co. KGaA
|
27.94 | 27,01% | 50,47% | 15.736,85 | 0% | -4,44% |
|
TSE:4503
Astellas Pharma
|
1487.00 | 0% | 0% | 2.666.170,81 | 4,98% | 0% |
